CropLife UK welcomes the prospect of simpler trade with Europe and the longer-term opportunities that closer UK–EU alignment could offer for the regulation of plant protection products (PPPs). However, following today’s announcement, significant questions remain about how the future regulatory regime will operate in Great Britain.

Model.Name

Our concern is not the direction of travel, but how alignment is implemented. The agreement establishes a limited transition timetable, but businesses need a clear operating model to retain existing products and uses, bring forward innovation and progress applications already with the regulator.

Without that clarity, uncertainty over regulatory requirements, costs and market access risks holding back investment and reducing the crop protection options available to British growers.

A Timetable Is Not an Operational Model

The transitional arrangements provide a framework for moving towards alignment. They do not, however, explain how the regulator and applicants will operate within the new system.

Businesses need to understand how HSE will interact with EU institutions and member states, how applications already under assessment will be handled, and how active substance and product renewals will operate. A clear mechanism is also needed to ensure British evidence informs decisions affecting uses in agriculture, horticulture and amenity settings.

Dave Bench, Chief Executive of CropLife UK, said:

“We support easier trade. What we have now is an agreement, but not yet a workable plan.

“Government must explain what businesses trading or using PPPs need to do, how the regulator will make decisions and how British growing conditions will be taken into account. Without that clarity, companies cannot plan investment and the regulator cannot plan its workload.”

HSE Checks Must Have A Clear Purpose

The proposed HSE checks could involve around 5,000 product and minor-use authorisations, each potentially covering multiple crops. This would represent a substantial undertaking alongside the regulator’s existing backlog.

Great Britain and the EU already apply essentially the same regulatory requirements for PPPs. Government must therefore explain the purpose and legal basis of the checks, the assessment criteria, and how they relate to the renewal processes already established in legislation.

In particular, applicants need certainty that products will not face a compliance check followed shortly afterwards by a full product renewal covering overlapping issues. Regulatory resources should be directed towards necessary assessments, rather than duplicative processes that increase costs and delay access to innovation.

Dave Bench said:

“Great Britain and the EU already apply essentially the same regulatory requirements for PPPs. Another round of checks must have a clear purpose; not duplicate assessments, add unnecessary costs or divert resources from getting new tools to growers.”

The process must be clear, pragmatic and proportionate, while maintaining proper regulatory scrutiny.

MRL Alignment Must Account for Authorised British Uses

Maximum residue levels (MRLs) are a particular concern. These are legal trading limits for pesticide residues in food and feed, set to reflect proper use of a pesticide in accordance with good agricultural practice (GAP), with consumer safety assessed as part of the process.

MRLs are not safety limits. Different MRLs can reflect different authorised uses and agricultural practices; a difference between countries does not, in itself, indicate that food is unsafe.

Since EU exit, EU MRL decisions have not necessarily taken account of authorised British uses. Automatically applying those decisions without considering GB GAP could therefore affect the continued authorisation of uses that have already been assessed under the GB regulatory framework.

This matters particularly for horticulture and niche crops, where alternative control options may be limited. Although transitional arrangements may provide short-term reassurance, they do not resolve whether those uses will remain available in the longer term.

Government must explain how HSE will assess uses against the applicable MRLs and how British residue data and use patterns will be considered. A lower EU MRL should not automatically mean the withdrawal of an authorised British use.

Safeguards for New Active Substances

CropLife UK welcomes the expected safeguard for three active substances approved in Great Britain while EU decisions remain outstanding.

Further clarity is needed on how other new active substances currently being assessed by HSE will be treated, whether subsequent GB approvals will qualify for equivalent arrangements, and how the safeguards will operate as EU decisions are reached.

These questions are important both for applicants making investment decisions and for growers planning future crop protection programmes.

British Evidence Must Inform Future Decisions

A well-managed transition can reduce disruption, but it cannot resolve every consequence of alignment. Unless the future system provides a meaningful route for British evidence to be considered, decisions on MRLs, new active substances and product authorisation amendments may apply without adequately reflecting British climate, pest pressures and growing conditions.

Dave Bench added:

“A well-managed transition could reduce disruption. It cannot remove the longer-term constraint on innovation or the risk that British growers lose access to tools due to the Government’s decision to rapidly align with EU decisions that have not taken British farming conditions into account.

“We will continue to work closely with Government and HSE through the implementation of the deal and beyond. British evidence must have a meaningful role in decisions affecting British farming, horticulture and amenity uses.”

Precision Breeding and Continuity of Supply

CropLife UK also welcomes the expected exemption for precision-breeding field trials in England. Clarity is needed on the route to market for varieties already in development if EU rules are subsequently adopted for marketing authorisations.

CropLife UK expects no immediate supply disruption for growers or distributors as a result of today’s announcement. Our members are working to keep effective crop protection tools available while engaging with Government and HSE on the detail of implementation.

Other News